2025 Annual Report of Independent Director of Yili Chuaning Biotechnology Co., Ltd. - Gao Xianli
As an independent director of Yili Chuaning Biotechnology Co., Ltd. (hereinafter referred to as "the Company"), I, Gao Xianli, have strictly fulfilled my duties in accordance with the relevant regulations such as the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Articles of Association, and the Management Measures for Independent Directors of Listed Companies. I have actively attended relevant meetings with a diligent and responsible work attitude, voted in accordance with the law, effectively promoted the standardized operation of the Company, and fully played the role of an independent director. The report on my performance in 2025 is as follows:
I. Personal Basic Information and Independence Statement
(1) Personal Basic Information
Born in 1979, Chinese nationality, no permanent residency abroad, PhD, professor, doctoral supervisor, member of the Democratic League. I obtained my PhD from the School of Food Science and Engineering at South China University of Technology. I have previously worked at Guangzhou Rixiang Food Co., Ltd. (2005-2008) and the School of Bioengineering at Jiangnan University (2010-2014). I am currently employed at the School of Food and Biological Engineering at Jiangsu University. My main research directions include the screening, modification, and application of fermentation microorganisms and enzymes with excellent performance, as well as the exploration, production/preparation, application, and mechanisms of bioactive substances. I have hosted and participated in over 20 projects (5 national-level); published over 100 academic papers; served as a review expert for the National Natural Science Foundation, guest editor for Frontiers in Nutrition (JCR Zone 1) and Foods (JCR Zone 1), and editorial board member for LWT-Food Science and Technology (JCR Zone 1, TOP); and applied for 30 national invention patents (1 PCT), with 19 granted (9 successfully transferred). I currently serve as an independent director of the Company.
(2) Independence Statement
- Neither I nor my immediate family members or major social relationships hold any positions in the Company or its subsidiaries, do not directly or indirectly hold more than 1% of the Company's issued shares, are not among the top ten shareholders, and do not hold positions in shareholder units or companies that directly or indirectly hold more than 5% of the Company's issued shares or among the top five shareholders.
- I have not provided financial, legal, consulting, or other services to the Company and its controlling shareholders or their subsidiaries, nor have I received any undisclosed additional benefits from the Company or its major shareholders or related parties.
- I do not hold any position in the Company other than that of an independent director, nor do I hold any position in the Company's major shareholders. I have no significant relationships with the Company, its management, or major stakeholders that could affect my independent and objective judgment. Therefore, there are no circumstances affecting my independence.
II. Performance in 2025
(1) Attendance at Board Meetings
In 2025, the Company held a total of 5 board meetings, and my attendance was as follows:
| Independent Director Name | Required Attendance (times) | Actual Attendance (times) | Proxy Attendance (times) | Absences (times) | Consecutive Absences |
|---|---|---|---|---|---|
| Gao Xianli | 5 | 5 | 0 | 0 | No |
I independently and prudently reviewed all proposals and voted in favor without objections, opposition, or abstentions.
(2) Attendance at Specialized Committees
| Committee Name | Required Attendance (times) | Actual Attendance (times) |
|---|---|---|
| Remuneration and Assessment Committee | 1 | 1 |
| Strategy and ESG Committee | 1 | 1 |
| Audit Committee | 6 | 6 |